Results 51 to 60 of about 3,245 (185)

Comparison of muscle pathology in riboflavin-responsive lipid storage myopathy before and after treatment: one case report and review of literature

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
Objective To study the muscular pathological characteristics in riboflavin-responsive lipid storage myopathy before and after treatment.  Methods A 10-year follow-up visit was made on a patient with riboflavin-responsive lipid storage myopathy, and ...
Ding-bang CHEN   +8 more
doaj  

Neurons containing retrogradely transported Fluoro-Gold exhibit a variety of lysosomal profiles: a combined brightfield, fluorescence, and electron microscopic study. [PDF]

open access: yes, 1989
The advantages of axonally transported Fluoro-Gold as a retrograde fluorescent marker are numerous. The objective of the present study was to determine whether transported Fluoro-Gold is visible in either semi-thin sections for light microscopy or thin ...
Fallon, JH   +3 more
core   +1 more source

Clinical characteristics and gene mutation analysis of riboflavin-responsive lipid storage myopathy: report of 3 cases in 2 families and review of literature

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
Objective The clinical manifestation and electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation of riboflavin-responsive lipid storage myopathy were analyzed for early diagnosis and treatment.mutation of riboflavin-responsive lipid storage
Ji-qing CAO   +11 more
doaj  

Stimulation of liver growth and DNA synthesis by glucosylceramide [PDF]

open access: yes, 1988
The nature of the growth‐stimulating effect of glucosylceramide was studied. Mice were injected intraperitoneally with emulsified glucosylceramide and conduritol B epoxide, an inhibitor of cerebroside glucosidase.
Datta, Subhash C., Radin, Norman S.
core   +1 more source

Research progress of electrophysiology for the diagnosis of metabolic myopathy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
Metabolic myopathies comprise a group of diverse disorders characterized by defects ofn energy metabolism in skeletal muscle cells, including glycogen storage disease (GSD), lipid storage myopathy (LSM) and mitochondrial myopathy.
Lei ZHAO, Li⁃ying CUI
doaj  

Die Schweizer Fälle von Splenohepatomegalie (Niemann-Pick) Ein Beitrag zur genetischen Abgrenzung der Phospatid-Lipoidosen [PDF]

open access: yes, 2017
In this paper a counterpart is given to the data of our investigation about the incidence of infantile amaurotic idiocy (Tay-Sachs) in Switzerland, published here in 1954. The term > is rather unclear and had to be critisised by Letterer. The diagnose of
Hanhart, E.
core  

Evidence-based treatment of metabolic myopathy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
Objective To evaluate the current treatments and possible adverse reactions of metabolic myopathy, and to develop the best solution for evidence-based treatment.
Yan LIN, Wen-wu ZHANG, Ling LIU
doaj  

Niemann-pick disease type A-a case report [PDF]

open access: yes, 2017
Niemann-Pick Disease is an autosomal recessive disorder of infancy, characterized by failure to thrive, hepatosplenomegaly and neurodegenerative changes. It is caused by inherited deficiency of an enzyme, acid sphingomyelinase.
Bindu, Rajan   +4 more
core   +2 more sources

Les biomarqueurs dans la maladie de Fabry: relation entre Sphingosine-1 phosphate et Lyso-Gb3 [PDF]

open access: yes, 2012
Problématique : La maladie de Fabry est une maladie métabolique à stockage lysosomal. C'est une maladie héreditaire à transmission récessive qui concerne l'enzyme alpha-Galactosidase A. Le gène de l'alpha-Galactosidase A (GLA) se trouve au niveau du bras
Moro, D.
core  

"Who receives statins? Variations in physicians’ prescribing patterns for patients with coronary heart disease, dyslipidemia, and diabetes" [PDF]

open access: yes
Our objective is to estimate the extent to which clinical and non-clinical factors are associated with physicians’ prescribing patterns for statins. The data are from the National Ambulatory Medical Care Survey for the period 1992 through 2004. The three
Bryan Townsend   +2 more
core  

Home - About - Disclaimer - Privacy